Intercept Pharmaceuticals: It Just Keeps Falling

The drug maker's share price has fallen 39% in the past four sessions, leaving analysts at odds over when it will hit a bottom.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.